People · Operator
Named in public records as an officer, director or promoter · active 2015–2024 · Biotechnology, Other Energy
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Autobahn Therapeutics, Inc. | — | Biotechnology | Series D+ | $100.8M | $1.1B | 2024 |
| PosiGen, Inc. | — | Other Energy | Series B | $54.4M | $225.6M | 2015 |
Timothy Anderson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Timothy Anderson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kristina Burow | 1 | 16 |
| Sasha Brown | 1 | 4 |
| Scott Dupcak | 1 | 4 |
| Michael Hammons | 1 | 4 |
| Harold Callais | 1 | 4 |
| Ali Iz | 1 | 4 |
| John Borkholder | 1 | 2 |
| Scott Giacobello | 1 | 2 |
| Kevin Finney | 1 | 2 |
| Thomas Cahill | 1 | 2 |
| Uwe J Schoenbeck | 1 | 1 |
| Philip J DeSouza | 1 | 1 |
| Benjamin Cravatt | 1 | 1 |
| Bonnie J Van Wilgenburg | 1 | 1 |
| Matthew Woods | 1 | 1 |
| Benjamin Norwood | 1 | 1 |
| Aaron Dirks | 1 | 1 |
| Margaret Anadu | 1 | 1 |
| Lisa Neyhart | 1 | 1 |
| Thomas Neyhart | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.